Literature DB >> 23904360

Coronary microvascular dysfunction in primary cardiomyopathies.

R Spoladore1, A Fisicaro, A Faccini, P G Camici.   

Abstract

Entities:  

Keywords:  Coronary Physiology

Mesh：

Year:  2013        PMID： 23904360     DOI： 10.1136/heartjnl-2013-304291

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  11 in total

1.  Right atrial pathology in arrhythmogenic right ventricular dysplasia.

Authors:  Guoliang Li; Guy H Fontaine; Shuanliang Fan; Yang Yan; Peter K Bode; Firat Duru; Robert Frank; Ardan M Saguner
Journal:  Cardiol J       Date:  2018-11-05       Impact factor: 2.737

Review 2.  Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome.

Authors:  Hicham Labazi; Aaron J Trask
Journal:  Pharmacol Res       Date:  2017-07-09       Impact factor: 7.658

3.  Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.

Authors:  Fabiola González-Herrera; Allysson Cramer; Pollyana Pimentel; Christian Castillo; Ana Liempi; Ulrike Kemmerling; Fabiana S Machado; Juan D Maya
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT.

Authors:  Wayne L Miller; Thomas R Behrenbeck; Cynthia H McCollough; Eric E Williamson; Shuai Leng; Timothy L Kline; Erik L Ritman
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-25       Impact factor: 2.357

Review 5.  Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.

Authors:  Paco E Bravo; Marcelo F Di Carli; Sharmila Dorbala
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 6.  Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms.

Authors:  Katie Anne Fopiano; Sawan Jalnapurkar; Alec C Davila; Vishal Arora; Zsolt Bagi
Journal:  Curr Cardiol Rev       Date:  2022

7.  Defining Coronary Flow Patterns: Comprehensive Automation of Transthoracic Doppler Coronary Blood Flow.

Authors:  Ian L Sunyecz; Patricia E McCallinhart; Kishan U Patel; Michael R McDermott; Aaron J Trask
Journal:  Sci Rep       Date:  2018-11-22       Impact factor: 4.379

Review 8.  Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction.

Authors:  Paolo Severino; Andrea D'Amato; Mariateresa Pucci; Fabio Infusino; Francesco Adamo; Lucia Ilaria Birtolo; Lucrezia Netti; Giulio Montefusco; Cristina Chimenti; Carlo Lavalle; Viviana Maestrini; Massimo Mancone; William M Chilian; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 6.208

9.  Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.

Authors:  Rui Si; Qian Zhang; Atsumi Tsuji-Hosokawa; Makiko Watanabe; Conor Willson; Ning Lai; Jian Wang; Anzhi Dai; Brian T Scott; Wolfgang H Dillmann; Jason X-J Yuan; Ayako Makino
Journal:  Cardiovasc Res       Date:  2020-05-01       Impact factor: 10.787

10.  Effect of Shexiang Tongxin dropping pill on stable coronary artery disease patients with normal fractional flow reserve and coronary microvascular disease: A study protocol.

Authors:  Yanli Lu; Xiaopeng Chu; Jiefang Zhang; Yanbo Zhao; Chongying Jin; Junhui Zhu; Guosheng Fu; Fuyu Qiu
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.